ghk cu clinical trial skin elasticity randomized Frontiers GHK-Cu for Skin Rejuvenation -
Description
T1 has been used in Phase III clinical trials with more than 4,000 patients, dosed continuously for 6 to 12 months in chronic hepatitis B, hepatitis C, and immunodeficiency indications
We make sure to provide a safe and effective peptide therapy experience
This represents preliminary evidence only
Powered by a0.5% concentration of GHK-Cu (Copper Peptide) and Hyal
